CRISPR-Cas9-induced genetic mosaicism in three species of the microcrustacean Daphnia
Genome · 2026
DOI: 10.1139/gen-2026-0049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genome, 2026. Verfasst von Sen Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biological Sciences, University of Missouri, Columbia, MO 65211, USA. Hauptthemen laut MEDLINE: Mosaicism, CRISPR-Cas Systems, Daphnia, Gene Editing. Die Arbeit nennt 19 Literaturangaben. Gefördert von: NIH, NSF.
Abstract (Originalsprache)
Genetic mosaicism can arise from in vivo CRISPR-Cas9 gene editing, especially in the embryos. This study evaluates the extent of genetic mosaicism resulted from CRISPR-Cas9-mediated knockout for 11 genes in the freshwater microcrustacean Daphnia magna, Daphnia pulex, and Daphnia sinensis. Based on extensive genotyping data of the asexually produced progenies of successfully edited females, we find strong evidence of mosaicism in 9 of these genes. The genotyping data also suggest that the gene editing activity can take place as early as the one-cell embryo stage and extends into the 32-cell and later stages. This study establishes genetic mosaicism as an important feature of Cas9-mediated gene editing in Daphnia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Biological Sciences, University of Missouri, Columbia, MO 65211, USA.
ORCID-Profile: Sen Xu
Förderung
- NIH
- NSF
Zitieren
APA
Xu, S., Neupane, S., & Wang, L. (2026). CRISPR-Cas9-induced genetic mosaicism in three species of the microcrustacean Daphnia. Genome. https://doi.org/10.1139/gen-2026-0049
Vancouver
Xu S, Neupane S, Wang L. CRISPR-Cas9-induced genetic mosaicism in three species of the microcrustacean Daphnia. Genome. 2026. doi:10.1139/gen-2026-0049
BibTeX
@article{Xu2026,
author = {Xu, Sen and Neupane, Swatantra and Wang, Li},
title = {CRISPR-Cas9-induced genetic mosaicism in three species of the microcrustacean Daphnia},
journal = {Genome},
year = {2026},
doi = {10.1139/gen-2026-0049}
}
EUVIMED